News

News Corporation filed a Form 8-K on November 9, 2026, reporting that it had provided its required daily share repurchase disclosures to the Australian Securities Exchange in connection with its previously announced $1 billion stock repurchase program, with the earliest event dated November 6, …

Pulmatrix, Inc. filed a Form 425 on November 9, 2026, disclosing that merger partner Eos SENOLYTIX, Inc. will present pre-clinical data on its lead compound PTC-2105 at the 19th Sarcopenia, Cachexia and Wasting Disorders International Conference on December 11, 2026, in Washington, D.C.

Adagene Inc. filed a Form 6-K on November 9, 2026, announcing the expected completion of the second closing of Sanofi's strategic investment following Adagene's achievement of Full Phase 2 Enrollment under the terms of the Securities Purchase Agreement dated June 30, 2025.

NeurAxis, Inc. filed its quarterly report on Form 10-Q with the SEC on November 9, 2026, covering the three and nine months ended September 30, 2026, disclosing a sharp increase in both revenue and operating losses compared to the prior-year period.

Turn Therapeutics Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 9, 2026, disclosing a net loss of $13,051,733 for the first nine months of the year.

Constellation Energy Corporation filed a current report with the SEC on November 9, 2026, announcing its results of operations and financial condition for the third quarter ended September 30, 2026, alongside an earnings conference call scheduled for the same date.

The Timken Company filed an 8-K on November 9, 2026, announcing that members of its management team will participate in three investor conferences in November and December 2026.